Certepetide

DB18721InvestigationalProtein Based Therapies

Certepetide: Overview.

Mechanism
Curator reviewed
Also known as
Ac-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-NH2 cyclic (1→9)-disulfide · Internalized-arginylglycylaspartic acid cyclic peptide · L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide · L-cysteine, l-cysteinyl-l-arginylglycyl-l-.alpha.-aspartyl-l-lysylglycyl-l-prolyl-l-.alpha.-aspartyl-, cyclic (1->9)-disulfide
Code names
CEND-1 · IRGD · LSTA-1

Resolves to

What you can answer from here — as of July 09, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Certepetide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account